April 2013 FDA Recall Drug by Qualitest Pharmaceuticals
D-298-2013 - Failed Tablet/Capsule Specifications

This Class II drug recall was voluntarily initiated by Qualitest Pharmaceuticals on April 19, 2013 for the product Drug. The FDA reported the reason for recall as failed tablet/capsule specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-298-2013

Reason for Recall
Failed Tablet/Capsule Specifications: One oversized tablet was found in a sealed 100 count bottle of Glimepiride at the retail level.
Initiated
04-19-2013
Reported
05-01-2013
Quantity
10,373 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Qualitest Pharmaceuticals
GLIMEPIRIDE TABLETS USP, 2 mg, 100-count tablets per bottle, Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-3745-21.

Batch or Lot Expiration Information

Lot# : C0671212A, Exp 12/14